Ad is loading...

PYPD

AS OF

Nov 21 closing price

Price

$3.43

Change

-$0.00 (-0.00%)

Capitalization

24.12M

75 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

PYPD Stock PYPD is expected to report earnings to rise+18.4% to -102 cents per share on November 13

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

PYPD - PolyPid Ltd

Q3'24

Est.

$-1.02

Q2'24

Beat

by $0.05

Q1'24

Beat

by $2.78

Q4'23

Missed

by $0.39

Q3'23

Beat

by $7.56

The last earnings report on June 30 showed earnings per share of -125 cents, beating the estimate of -130 cents. P/B Ratio (14.837) is normal, around the industry mean (14.171). P/E Ratio (0.000) is within average values for comparable stocks, (100.668). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.979). PYPD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (227.804). With 11.40K shares outstanding, the current market capitalization sits at 23.74M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com